Zassi Medical Evolutions Launches New Online Company That Uses 'Business DNA' to Deliver Advanced Discovery, Collaboration, and Business Intelligence Tools to the Medical Devic...(Commercial Analysis -- Due Diligence ...),Health

The company recognizes the value provided by the ability to gain insights earlier in the innovation, development and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system delivers this decision support knowledge in minutes providing exceptional value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund or provide services for medical technologies.

"The $250B global medical device industry invests more than $40B annually in new product innovation and development alone. As such, it requires rapid decision making, comprehensive planning and increased efficiency in terms of technology due diligence, business networking and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise," states Peter M. von Dyck, e-Zassi's Founder and Chief Executive Officer.

Special Charter Memberships are available now for a limited time. For more information regarding
'/>"/>